Cargando…
Biomarker for early renal microvascular and diabetic kidney diseases
Recognition of early stage of diabetic kidney disease, under common practice using biomarkers, namely microalbuminuria, serum creatinine level above 1 mg/dL and accepted definition of diabetic kidney disease associated with creatinine clearance value below 60 mL/min/1.73 m(2), is unlikely. This woul...
Autores principales: | Futrakul, Narisa, Futrakul, Prasit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014362/ https://www.ncbi.nlm.nih.gov/pubmed/28494191 http://dx.doi.org/10.1080/0886022X.2017.1323647 |
Ejemplares similares
-
Vascular Homeostasis and Angiogenesis Determine Therapeutic Effectiveness in Type 2 Diabetes
por: Futrakul, Narisa, et al.
Publicado: (2011) -
Detection of DKD stage 1 and treatment are essential
por: Futrakul, Narisa, et al.
Publicado: (2018) -
Renal microvascular lesions in lupus nephritis
por: Ding, Ying, et al.
Publicado: (2019) -
Review of the efficacy of AST-120 (KREMEZIN(®)) on renal function in chronic kidney disease patients
por: Asai, Mayumi, et al.
Publicado: (2019) -
The role of kidney injury biomarkers in COVID-19
por: Su, Lianjiu, et al.
Publicado: (2022)